Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates in two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expressed on activated macrophages for a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (PET),...
Industry: Biotechnology
Sector: Healthcare
Phone: 614 793 7500
Fax: 614 793 7520
Address:
4995 Bradenton Avenue, Suite 240, Dublin, United States
